Slow CD4⁺ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.

However, the difference in HBV viral load between HBV genotypes after 24 months did not reach statistical significance (Fisher's exact P = .437).

also in 111,027 other papers

This large cohort from Tanzania also reported a marginally significant recovery at 12 months; however, in our cohort, there were no significant differences in immunologic recovery between HIV/HBV-coinfected and HIV-monoinfected participants at 12 months [ 17 ].

also in 26,082 other papers